These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33663067)

  • 1. Plasma metabolites were associated with spatial working memory in major depressive disorder.
    Du Y; Wei J; Yang X; Dou Y; Zhao L; Qi X; Yu X; Guo W; Wang Q; Deng W; Li M; Lin D; Li T; Ma X
    Medicine (Baltimore); 2021 Feb; 100(8):e24581. PubMed ID: 33663067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulations of amino acid metabolism and lipid metabolism in urine of children and adolescents with major depressive disorder: a case-control study.
    Jiang Y; Cai Y; Teng T; Wang X; Yin B; Li X; Yu Y; Liu X; Wang J; Wu H; He Y; Zhu ZJ; Zhou X
    Psychopharmacology (Berl); 2024 Aug; 241(8):1691-1703. PubMed ID: 38605232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in visual cortical activation and connectivity with prefrontal cortex during working memory updating in major depressive disorder.
    Le TM; Borghi JA; Kujawa AJ; Klein DN; Leung HC
    Neuroimage Clin; 2017; 14():43-53. PubMed ID: 28138426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
    Young KD; Drevets WC; Dantzer R; Teague TK; Bodurka J; Savitz J
    Brain Behav Immun; 2016 Aug; 56():335-42. PubMed ID: 27091600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory cytokine levels, cognitive function, and suicidal symptoms of adolescents and young adults with major depressive disorder.
    Chen MH; Bai YM; Hsu JW; Huang KL; Tsai SJ
    Eur Arch Psychiatry Clin Neurosci; 2024 Oct; 274(7):1681-1687. PubMed ID: 38492052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential urinary metabolites related with the severity of major depressive disorder.
    Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
    Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic features of adolescent major depressive disorder: A comparative study between treatment-resistant depression and first-episode drug-naive depression.
    Gan X; Li X; Cai Y; Yin B; Pan Q; Teng T; He Y; Tang H; Wang T; Li J; Zhu Z; Zhou X; Li J
    Psychoneuroendocrinology; 2024 Sep; 167():107086. PubMed ID: 38824765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Brain Aging and Its Association With Working Memory Performance in Major Depressive Disorder.
    Ho NCW; Bethlehem RAI; Seidlitz J; Nogovitsyn N; Metzak P; Ballester PL; Hassel S; Rotzinger S; Poppenk J; Lam RW; Taylor VH; Milev R; ; Bullmore ET; Alexander-Bloch AF; Frey BN; Harkness KL; Addington J; Kennedy SH; Dunlop K
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Aug; 9(8):786-799. PubMed ID: 38679324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the neural basis of cognitive control dysfunction in mood disorders.
    Breukelaar IA; Erlinger M; Harris A; Boyce P; Hazell P; Grieve SM; Antees C; Foster S; Gomes L; Williams LM; Malhi GS; Korgaonkar MS
    Bipolar Disord; 2020 May; 22(3):286-295. PubMed ID: 31604366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breathomics profiling of metabolic pathways affected by major depression: Possibilities and limitations.
    Gbaoui L; Fachet M; Lüno M; Meyer-Lotz G; Frodl T; Hoeschen C
    Front Psychiatry; 2022; 13():1061326. PubMed ID: 36590606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial working memory performance in children and adolescents with major depressive disorder and dysthymic disorder.
    Vance A; Winther J
    J Affect Disord; 2021 Jan; 278():470-476. PubMed ID: 33017674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased gamma connectivity during working memory retention following traumatic brain injury.
    Bailey NW; Rogasch NC; Hoy KE; Maller JJ; Segrave RA; Sullivan CM; Fitzgerald PB
    Brain Inj; 2017; 31(3):379-389. PubMed ID: 28095052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased working memory capacity among individuals with a mood disorder who have increased metabolic burden.
    Peterman JS; Marshall DF; Lamping E; Easter RE; Babu P; Langenecker SA; McInnis MG; Ryan KA
    J Affect Disord; 2020 Apr; 266():387-393. PubMed ID: 32056904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
    Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
    Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary analysis of neurotransmitter metabolism and cognitive function in first-diagnosed, drug-naïve adult patients with major depressive disorder.
    Zhao T; Luo J; Liu T; Xie K; Tang M
    Behav Brain Res; 2024 Sep; 473():115193. PubMed ID: 39122091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder.
    Wu Z; Yu H; Tian Y; Wang Y; He Y; Lan T; Li Y; Bai M; Chen X; Chen Z; Ji P; Zhang H; Jin X; Song J; Cheng K; Xie P
    Front Psychiatry; 2021; 12():810302. PubMed ID: 35264984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.